Consistent with this it is worth noting that the breast cancer cell line, MCF7, is strongly arrested with CDK4 inhibitors, MDM2 levels are decreased and there is some conversion to senescence as measured by multiple hallmarks; however upon removal of the CDK4 inhibitor half the cells can return to cycle. This evidence concerns the gene MDM2 and breast carcinoma.